Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Pharmaceutical Packaging and Palletization

Active

Federal

Response Deadline07/27/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract requires the packaging of Lidocaine Hydrochloride and Dextrose Injection in strict compliance with ASTM D3951 standards and RP001 specifications, ensuring pharmaceutical integrity and regulatory adherence throughout the packaging process. All units must be arranged and secured on pallets to meet military-compliant palletization requirements for shipment through the Defense Logistics Agency, with emphasis on durability, stability, and traceability during transport. The place of performance is identified as Williamsburg, Virginia, with a ZIP code of 23185-5830, indicating the physical location where the packaging and palletization activities must occur. This subcontract, categorized under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, is issued by the Department of Defense through the Medical Supply Chain Pharm FSA and is open for response until July 27, 2026. The solicitation is not set aside for any specific small business or minority designation, and bids must adhere to all technical, logistical, and documentation standards mandated by military supply chain protocols. The primary objective is to deliver a fully compliant, ready-for-issue pharmaceutical product package that meets the quality and handling expectations necessary for DoD medical supply operations.

General Info

Package Lidocaine Dextrose Injection per ASTM D3951 and RP001, palletize militarily, deliver to Williamsburg VA by 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

WILLIAMSBURG, VA, 23185-5830, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 19

subcontract

Response DeadlineJul 27

Submission deadline

Response Deadline

07/27/2026, 05:00:00 PM UTCin 7 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Package Lidocaine Hydrochloride and Dextrose Injection per ASTM D3951 and RP001, including military-compliant palletization for DLA shipment.

Similar Contracts

Same NAICS industry code

Pharmaceutical Supply and DeliveryThe contract entails the procurement, packaging, and delivery of DIPHENHYDRAMINE HYDROCHLORIDE INJECTION to a U.S. Navy vessel operating overseas, ensuring timely and reliable medical supply support in a deployed environment. All products must meet stringent regulatory requirements including FDA standards for pharmaceuticals and Defense Logistics Agency specifications for military-grade medical materiel, with packaging designed to withstand harsh transit conditions and maintain sterility and efficacy throughout the supply chain. The shipping terms are FOB destination, meaning the supplier assumes full responsibility for the goods until they are delivered to the vessel’s location, which underscores the importance of secure, traceable, and compliant logistics. The contract is classified as a subcontract under NAICS code 325412, relating to pharmaceutical preparation manufacturing, and is managed by the Defense Logistics Agency on behalf of the Department of Defense. Although the solicitation number and specific point of contact are not provided, the contract is accessible via the DIBBS system using the referenced award and delivery details. Compliance with all applicable military and federal regulations is mandatory, and the supplier is expected to adhere to strict quality control, documentation, and delivery timelines to support operational readiness of the deploying naval unit.

Defense Logistics Agency

POSTED

about 8 hours ago

DEADLINE

Medical Pharmaceutical Supply – Sodium Chloride InjectionThe contract encompasses the supply of sterile, nonpyrogenic Sodium Chloride Injection intended for fluid and electrolyte replenishment, with all products required to meet United States Pharmacopeia standards and medical labeling requirements. The packaging must comply with stringent regulatory specifications to ensure safety, purity, and suitability for clinical use. This procurement is issued as a subcontract under the NAICS code 325412, targeting manufacturers or distributors capable of delivering reliable, high-quality pharmaceuticals in accordance with federal medical supply protocols. The place of performance is designated as Sea Girt, New Jersey, with a zip code of 08750-0000, indicating the operational location for fulfillment and delivery. The solicitation was posted on July 20, 2026, with a firm response deadline of July 27, 2026, placing this as a time-sensitive opportunity for qualified vendors. The contracting agency is the Department of Defense through its Medical Supply Chain Pharm FSA, signaling the product is destined for use within military or government healthcare systems. All bidders must ensure their submissions align with the requirements specified in the DIBBS portal, accessible via the provided link, and be prepared to demonstrate capacity for consistent production, quality control, and timely delivery of large-scale pharmaceutical quantities to meet critical operational needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

Pharmaceutical Supply – Flumazenil InjectionThe contract involves the supply and delivery of one vial of Flumazenil Injection, a Schedule IV controlled substance, required to meet all applicable regulatory standards set by the FDA, DEA, and DLA. The item must be delivered FOB Destination to Fort Campbell, KY, ensuring compliance with federal control and transportation protocols for controlled pharmaceuticals. The procurement is issued under a subcontract by the Defense Logistics Agency on behalf of the Department of Defense, with the NAICS code 325412 indicating manufacturing of pharmaceutical preparations. The solicitation was posted on July 20, 2026, and the performance location is specifically designated to support military medical operations at Fort Campbell. All documentation, handling, and delivery procedures must adhere strictly to federal controlled substance regulations to ensure lawful and secure transit and receipt.

Defense Logistics Agency

POSTED

about 8 hours ago

DEADLINE

Chlorine Water Purification Tablet SupplyThe contract involves the manufacture or supply of 4,000 pounds of chlorine-based water purification tablets designated by NSN 6850016128944 and manufacturer part number 03093, intended for use by the Department of Defense through the Defense Logistics Agency. This is a subcontract awarded under NAICS code 325412, which corresponds to the manufacturing of other chemical products, indicating that the products are specialized chemical formulations optimized for potable water treatment in military or operational settings. The contract was posted on July 20, 2026, and is not subject to any specific small business set-aside provisions. Performance of this contract requires the delivery of bulk quantities of tablets meeting exact military specifications for efficacy, shelf life, and packaging consistency, with no designated city or state for performance noted, suggesting fulfillment may occur across multiple locations or at the contractor’s facility prior to distribution through DLA logistics channels. The award is linked to an existing procurement vehicle under contract number SPE4AX16D9008 with delivery order SPE4A626FCVLC, implying this is part of a larger logistical effort to maintain water safety standards across deployed or remote military operations. The lack of a public point of contact indicates standardized communication channels are managed through official DLA systems.

Defense Logistics Agency

POSTED

about 8 hours ago

DEADLINE

APPLICATOR, SILVER NITRThe applicator consists of a topical medical device containing a fused mixture of 75% silver nitrate and 25% potassium nitrate, with each applicator measuring six inches in length. It is restricted to prescription use only and packaged in containers of 100 units. Storage requires keeping the product in its original closed container at room temperature in a dark, dry location away from organic or oxidizable materials. The item is regulated by the FDA and subject to a 24-month non-extendable shelf life under TYPE I (CODE M) requirements. Hazardous materials protocols apply, mandating submission of a current Material Safety Data Sheet (MSDS) to DLA.MSDS@DLA.MIL and physical inclusion of the MSDS with every shipment, with packaging conforming to SPE2DP-26-T-4199 and applicable 49 CFR and ICAO standards. The NSN is 6505-00-299-9672, and the solicitation number is SPE2DP-26-T-4199, issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with a response deadline of July 27, 2026, and a required delivery within five days of award. The contracting official must submit an EBS referral for FDA confirmation, including bidder and manufacturer details. Covered defense information requirements and removal of government identification from non-accepted supplies also apply.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

POVIDONE-IODINE CLEANSPOVIDONE-IODINE CLEANSING SOLUTION, USP, with 7.5% active ingredient, is designated for external use only and must be delivered with at least 31 months of shelf life remaining from a total 36-month expiration period. The product is packaged in 1-gallon bottles, identified by unit of issue BT, and must be stored at 25°C (77°F) with permitted excursions between 15°C and 30°C (59°F to 86°F). It is regulated by the FDA and classified as a hazardous material under Federal Standard No. 313-E, requiring suppliers to provide Safety Data Sheets and Hazard Communication Standard-compliant labels in accordance with 29 C.F.R. 1910.1200. Employee training on these requirements is mandatory. Packaging must meet DLA’s Master List of Technical and Quality Requirements, including RP001 for packaging and RQ011 for removal of government identification from non-accepted supplies, superseding MIL-STD-129 in favor of Medical Marking Standard No. 1. All units must be sealed, commercially packaged, and palletized per DLA guidelines to ensure safe transport under the lowest possible freight rates. The contract specifies two line items totaling 7 gallons (2 BT + 5 BT), both with identical product specifications, delivery requirements, and compliance obligations. Delivery is FOB destination within 20 days, with zero quantity variance permitted and inspection and acceptance occurring at the destination. Two delivery points are listed: one in San Diego, California, for USNS JOHN GLENN and another in Norfolk, Virginia, for USNS CODY. Shipments must use the fastest traceable means, explicitly prohibiting parcel post. Each shipment must be labeled with RDD 777, project codes, and government-specific identifiers, and the original required delivery date is July 22, 2026. The contract is issued under solicitation SPE2DP-26-T-4200, referencing NSN 6505-00-994-7224 and approved manufacturer part numbers from Cardinal Health and Purdue Pharma. All technical, quality, and packaging requirements take precedence over any commercial standards not explicitly endorsed by the DLA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

SODIUM HYPOCHLORITE SOSodium hypochlorite solution, modified at 0.125 percent strength, is being procured in 480 milliliter (16 oz) bottles under the part number NDC00436-0672-16 by Century Pharmaceuticals Inc for use as a medical disinfectant. The item is classified as a FDA-regulated drug with a strict 12-month non-extendable shelf life and must be stored at controlled room temperature. Packaging and marking must conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all shipments must comply with DLA packaging requirements and hazardous materials handling guidelines. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest rate. The delivery is FOB destination with zero variance allowed and must be completed within 20 days of contract award, with inspection and acceptance occurring at the delivery point. The destination is the USNS MERCY medical treatment facility, and traceable freight shipping is required—parcel post is prohibited. The NSN is 6505015887606, and the solicitation number is SPE2DP-26-T-4202 with a response deadline of July 27, 2026 and a required delivery date of July 20, 2026. All bidders must provide source and part number details and comply with DLA’s master list of technical and quality requirements, including those referenced under RS011, RA001, RP001, and RQ011. The contract also includes covered defense information provisions and requires adherence to specific labeling and shipment standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

ALCOHOL, USPThe contract is for 95% ethyl alcohol, USP, 190 proof, in a 5-gallon metal drum unit, totaling two drums, with the NSN 6505-00-104-9000, under solicitation SPE2DS-26-T-250G. The material must meet strict technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, with compliance controlled by the version in effect on the solicitation issue date or award date, depending on acquisition size. Packaging must follow Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and must ensure a minimum of 31 months of shelf life remains at time of receipt, out of a total 36-month shelf life. The product is designated for industrial, pharmaceutical, flavor, fragrance, or laboratory use only and is classified as a DOT Hazard Class 3 flammable liquid requiring careful handling. Each shipment must include a current Safety Data Sheet, which must also be electronically transmitted to DLA.MSDS@DLA.MIL with the required cover sheet P-75, and a physical copy must accompany each delivery. Packaging must comply with 49 CFR and ICAO regulations for hazardous materials, and the alcohol must be stored in a cool, dry place away from direct sunlight with appropriate personal protective equipment and ventilation during use. The item is regulated by the FDA, and buyers must submit referrals via EBS to confirm bidder and manufacturer details, including part numbers and contact information. The delivery window is 20 days after award, with the solicitation closing on July 27, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 8 hours ago

DEADLINE

LABETALOL HYDROCHLORIDLabetalol Hydrochloride Injection USP, 5 mg per mL in 40 mL vials, is being procured under solicitation SPE2DP-26-T-4201 with a total quantity of four vials, each containing 40 mL, for delivery within five days FOB destination. The item is regulated by the FDA and carries a non-extendable shelf life of 24 months as per RS001 requirements for Type I (Code M) pharmaceuticals. Packaging must comply with MIL-STD-2073-1E and the latest Medical Marking Standard No. 1, and all supplies must be labeled with the NDC number 00143-9623-01 under Hikma Pharmaceuticals USA Inc. The contract mandates strict zero variance in quantity and requires inspection and acceptance at the destination point. Technical and quality specifications are governed by the DLA Master List of Technical and Quality Requirements, and government identification must be removed from any non-accepted supplies. The contracting official must submit an EBS referral to the product specialist with full bidder and manufacturer details prior to award. The item is authorized under the DoD unit of issue VI, and procurement is managed by the Department of Defense through the Medical Supply Chain PHARM FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

6505--Supplies - Radioactive Isotopes - Ann ArborThe Department of Veterans Affairs is soliciting bids under RFQ 36C25026Q0724 for the supply of radioactive isotopes to support medical services at the Ann Arbor VA and Toledo CBOC. This is a full and open competition with no set-aside restrictions, and responses are due by August 13, 2026, at 3:00 PM Eastern Time. The solicitation falls under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, and the contract will be awarded based on competitive evaluation of proposals submitted in response to the combined solicitation. The contracting office is the 250-NETWORK Contract Office 10 located in Dayton, Ohio, and all deliveries are expected to be made to the specified VA facilities, though exact delivery locations are not detailed in the provided data. Kellie Konopinski, Contracting Officer, serves as the primary point of contact and can be reached via phone at 734-222-4330 or email at kellie.konopinski@va.gov for inquiries regarding this procurement.

250-NETWORK Contract Office 10 (36C250)

POSTED

about 13 hours ago

DEADLINE

Medical Adhesive Applicator Manufacturing and SupplyThe contract requires the manufacture and supply of sterile, flammable medical adhesive applicators impregnated with Compound Benzoin Tincture specifically designed for surgical adhesion enhancement. All products must comply with stringent regulatory standards set by the FDA, including requirements for sterility, shelf-life stability, accurate labeling, and secure packaging to ensure safety and efficacy in clinical environments. The scope encompasses full production capability with complete quality control throughout the manufacturing process and adherence to all applicable medical device protocols. The solicitation is issued under the NAICS code 325412 for pharmaceutical and medicine manufacturing and is classified as a subcontract within the Department of Defense’s Medical Supply Chain framework. The performance location is designated as Fort Stewart, Georgia, with a response deadline of July 27, 2026. The posting date of July 19, 2026, indicates a limited eight-day window for interested parties to submit proposals, and the contract is administered through the Defense Logistics Agency’s DIBBS system under the reference number SPE2DS26T247E.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Pharmaceutical Supply of Antacid TabletsThe contract involves the supply of eight units of Aluminum, Magnesium, Simethicone Tablets, identified by NSN 6505014731770 and NDC 00904-6700-60, with all packaging and labeling required to comply with FDA regulations and include the NSN, NDC, and CAGE codes. The product is intended for pharmaceutical use and must be fully prepared and ready for immediate shipment upon delivery. This is a subcontract under the Defense Logistics Agency, part of the Department of Defense, and falls under the NAICS code 325412 for pharmaceutical and medicinal product manufacturing. The solicitation was posted on July 19, 2026, and the award is linked to contract SPE2DX25D8022 with delivery order SPE2D926F7447, indicating active procurement activity within the military logistics system.

Defense Logistics Agency

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Regulatory Compliance and Data Safety for CUIThe contract mandates strict adherence to NIST SP 800-171 and DFARS 252.204-7012 to ensure the protection of Covered Defense Information throughout all phases of performance. Compliance requires the implementation of robust security controls to safeguard Controlled Unclassified Information, including secure handling, access restrictions, audit logging, and system integrity measures. All subcontractors must demonstrate proven capability to meet these federal cybersecurity standards without exception, and failure to comply may result in contract termination or legal consequences. Performance is to be conducted at the specified location in Sea Girt, New Jersey, under the auspices of the Department of Defense through the Medical Supply Chain Pharm FSA. The subcontract is classified under NAICS code 541611, indicating it pertains to management, scientific, and technical consulting services. Submission of responses is due by July 27, 2026, with the solicitation posted on July 20, 2026. Contractors must ensure their cybersecurity posture aligns fully with federal requirements, including documentation, training, and continuous monitoring, to maintain eligibility and protect sensitive defense data.

Administrative Management and General Management Consulting Services

POSTED

about 8 hours ago

DEADLINE

Traceable Medical Logistics and Delivery to DestinationThe contract requires the transportation of medical supplies to Sea Girt, New Jersey, with full traceability throughout the entire logistics chain to ensure accountability and integrity of the cargo. All shipments must be delivered under FOB destination terms, meaning ownership and risk transfer to the recipient only upon arrival at the specified location. Compliance with all Department of Defense Defense Logistics Agency delivery and inspection standards is mandatory, including adherence to documentation, packaging, labeling, and handling protocols aligned with federal medical supply protocols. The work must be performed under a subcontract structure with a NAICS code of 484121, indicating specialized freight trucking services are required to meet the precision and security needs of medical logistics. Bids must be submitted by July 27, 2026, following a solicitation issued on July 20, 2026, through the DLA’s DIBBS system, and the performance location is strictly designated as Sea Girt, NJ with a zip code of 08750-0000.

General Freight Trucking, Long-Distance, Truckload

POSTED

about 8 hours ago

DEADLINE

Hazardous & Medical Materials Packaging and LabelingThe contract mandates the repackaging and labeling of medical and hazardous materials to ensure full compliance with OSHA, MIL-STD-129, and MMS NO. 1 standards, covering all aspects of safe handling, transportation, and identification. This work is critical for maintaining regulatory adherence and operational readiness within military and federal medical supply chains, requiring precise labeling, durable packaging, and documented quality control procedures to meet stringent defense and safety requirements. The contract is structured as a subcontract under the NAICS code 323113, indicating specialized printing and related support activities tailored to government specifications. Performance is required at Sea Girt, New Jersey, with a response deadline of July 27, 2026, and the solicitation was posted on July 20, 2026. The awarding agency is the Medical Supply Chain Pharm FSA under the Department of Defense, emphasizing the defense-critical nature of the materials and services involved. All work must align with established federal guidelines for hazardous material identification and logistics integrity, and the successful vendor must demonstrate capability in handling sensitive medical supplies through certified processes and proven compliance experience. The contract details are accessible via the DIBBS platform for qualified subcontractors to review and submit proposals.

Commercial Screen Printing

POSTED

about 8 hours ago

DEADLINE

SODIUM CHLORIDE INJECTSodium Chloride Injection is a sterile, nonpyrogenic intravenous solution designated for fluid and electrolyte replenishment, serving as a source of water and essential electrolytes. It contains no antimicrobial agents and is supplied in single-dose containers, intended for medical use under strict aseptic conditions. The product must comply with stringent packaging and marking requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be labeled in accordance with SPE2DP-26-T-4198. Each unit must be sealed in protective packaging to prevent damage or breakage and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate to the delivery point. The product must be stored in moisture barrier overwrap at room temperature (25°C/77°F), avoiding excessive heat, and must maintain a shelf life of 15 months with no more than two months elapsed between manufacture and government delivery. It is manufactured by Baxter Healthcare Corporation under part number 2B1313Q and identified by NSN 6505014622120, with a unit of issue of PG. The contract specifies a single unit quantity of one PG to be delivered within 20 days FOB destination, with zero variance permitted in quantity and inspection and acceptance occurring at the point of delivery. The solicitation under number SPE2DP-26-T-4198, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, requires compliance with the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition size. The product must be procured under the DoD authorized unit of issue, referenced via official DLA documentation. All documentation, including marking and packaging, must strictly adhere to current DLA standards, and technical specifications are incorporated by reference. The point of contact is Meghan Smink, with the place of performance identified as Sea Girt, NJ, 08750-0000, and the response deadline for bids closing in July 2026.

Medicinal and Botanical Manufacturing

POSTED

about 8 hours ago

DEADLINE

Subcontract Management for Commercial Items (via WAWF)The contract focuses on subcontract administration for commercial items using the Wide Area WorkFlow system to manage invoicing, delivery tracking, and contract acceptance processes. It requires the contractor to ensure seamless integration with WAWF to maintain accurate and timely documentation throughout the lifecycle of subcontracts, supporting efficient procurement and fulfillment under the Department of Defense’s Medical Supply Chain Pharm FSA. All activities must align with federal requirements for commercial item contracting and be performed in support of operations tied to the FPO ZIP code 96674. Responses are due by July 27, 2026, with the solicitation posted on July 19, 2026. The NAICS code 541611 indicates the work falls under Management Consulting Services, implicating a need for administrative expertise rather than direct supply or manufacturing. The contract type is a subcontract, meaning the successful offeror will operate under a prime contractor’s agreement, managing subordinate vendor relationships with strict compliance to DOD procurement standards. All tasks must be delivered electronically through DIBBS, as referenced by the provided UI link, and no set-aside provisions are specified, making it open to all eligible businesses.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Supplier of MOXIFLOXACIN HYDROCHLORIDE TABLETSThe contract requires the supply of bulk MOXIFLOXACIN HYDROCHLORIDE TABLETS in a quantity of 15,000 bottles, adhering strictly to United States Pharmacopeia and federal procurement standards. The solicitation is issued under the NAICS code 325412 for pharmaceutical manufacturing and is classified as a subcontract, with the Medical Supply Chain Pharm FSA acting on behalf of the Department of Defense as the awarding agency. All delivered product must meet exacting quality and compliance criteria to ensure suitability for federal use. The place of performance is designated as FPO with a ZIP code of 96674, indicating delivery to a military post office location, and the response deadline is set for July 27, 2026. Interested suppliers must submit proposals by this date to be considered, with the opportunity to bid via the DIBBS platform using the provided link.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Regulatory Compliance and Quality Assurance for Pharmaceutical DeliveriesThis contract requires adherence to current good manufacturing practices cGMP FDA regulations and military quality standards for all pharmaceutical deliveries to ensure product integrity and compliance throughout the supply chain. Key responsibilities include conducting preshipment audits to verify product quality and documentation, maintaining full traceability from manufacturer to final destination, and providing on site inspection support at the point of delivery to confirm compliance with all regulatory and operational requirements. All activities must align with the stringent expectations of the Department of Defense’s Medical Supply Chain Pharmaceutical FSA and ensure that products intended for military use meet the highest benchmarks for safety efficacy and accountability. The performance location is designated as FPO with a zip code of 96674 indicating a military postal address potentially serving overseas or remote military facilities. The solicitation was posted on July 19 2026 with a response deadline of July 27 2026 and is classified as a subcontract under NAICS code 541380 which corresponds to other scientific and technical consulting services. The contract emphasizes rigorous quality control measures and is aimed at supporting critical medical supply operations within the Department of Defense’s pharmaceutical distribution network.

Testing Laboratories and Services

POSTED

DEADLINE